Changes of PSMA expression on [18F]PSMA1007 PET are not correlated with morphological changes in patients with metastatic renal cell cancer undergoing tyrosine kinase and checkpoint inhibitor treatment

被引：0
|
作者：
Kunte, Sophie [1 ]
Unterrainer, Lena [2 ,3 ]
Unterrainer, Marcus [4 ]
Holzgreve, Adrien [1 ]
Rodler, Severin [5 ]
Kunz, Wolfgang [6 ]
Stief, Christian
Bartenstein, Peter
Staehler, Michael [5 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Nucl Med, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Dept Nucl Med, Munich, Germany
[3] UCLA, Dept Nucl Med, Los Angeles, CA USA
[4] Ludwig Maximilians Univ Munchen, Munich, Germany
[5] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Urol, Munich, Germany
[6] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Radiol, Munich, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1052
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Comparison of [18F]PSMA-1007 with [68Ga]Ga-PSMA-11 PET/CT in Restaging of Prostate Cancer Patients with PSA Relapse
    Hoffmann, Manuela A.
    von Eyben, Finn Edler
    Fischer, Nicolas
    Rosar, Florian
    Muller-Hubenthal, Jonas
    Buchholz, Hans-Georg
    Wieler, Helmut J.
    Schreckenberger, Mathias
    CANCERS, 2022, 14 (06)
  • [22] Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer
    Jisu Kim
    Seunghwan Lee
    Dongwoo Kim
    Hyun Jeong Kim
    Kyeong Taek Oh
    Sun Jung Kim
    Young Deuk Choi
    Frederik L. Giesel
    Klaus Kopka
    Alexander Hoepping
    Misu Lee
    Mijin Yun
    European Journal of Nuclear Medicine and Molecular Imaging, 2024, 51 : 1763 - 1772
  • [23] Assessment of malignancy and PSMA expression of uncertain bone foci in [18F]PSMA-1007 PET/CT for prostate cancer—a single-centre experience of PET-guided biopsies
    Bernd Vollnberg
    Ian Alberts
    Vera Genitsch
    Axel Rominger
    Ali Afshar-Oromieh
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 3910 - 3916
  • [24] Combination of [18F]FDG and [18F]PSMA-1007 PET/CT predicts tumour aggressiveness at staging and biochemical failure postoperatively in patients with prostate cancer
    Kim, Jisu
    Lee, Seunghwan
    Kim, Dongwoo
    Kim, Hyun Jeong
    Oh, Kyeong Taek
    Kim, Sun Jung
    Choi, Young Deuk
    Giesel, Frederik L.
    Kopka, Klaus
    Hoepping, Alexander
    Lee, Misu
    Yun, Mijin
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (06) : 1763 - 1772
  • [25] nterobserver agreement for [18F]F-PSMA1007 PET/CT images according to the EPSMA criteria in prostate cancer patients.
    Liberini, Virginia
    Balma, Michele
    Nicolotti, Daniele
    Buschiazzo, Ambra
    Peano, Simona
    Papaleo, Alberto
    Bianchi, Andrea
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63
  • [26] High detection sensitivity in [18F]PSMA-1007 PET: initial experience focusing on biochemical recurrence in prostate cancer patients
    Watabe, T.
    Uemura, M.
    Soeda, F.
    Naka, S.
    Sasaki, H.
    Kamiya, T.
    Shimosegawa, E.
    Kato, H.
    Nonomura, N.
    Giesel, F. L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S365 - S366
  • [27] Correction to: Prospective intra‑individual blinded comparison of [18F]PSMA‑1007 and [68 Ga]Ga‑PSMA‑11 PET/CT imaging in patients with confirmed prostate cancer
    David A. Pattison
    Maciej Debowski
    Brook Gulhane
    Evyn G. Arnfield
    Anita M. Pelecanos
    Peter L. Garcia
    Melissa J. Latter
    Charles Y. Lin
    Matthew J. Roberts
    Stuart C. Ramsay
    Paul A. Thomas
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 789 - 789
  • [28] PET/CT Imaging 2 Hours After Injection of [18F]PSMA1007 Can Lead to Higher Staging of Prostate Cancer Than Imaging After 1 Hour
    Hvittfeldt, E.
    Bitzen, U.
    Minarik, D.
    Oddstig, J.
    Olsson, B.
    Tragardh, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S517 - S517
  • [29] High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients
    Watabe, Tadashi
    Uemura, Motohide
    Soeda, Fumihiko
    Naka, Sadahiro
    Ujike, Takeshi
    Hatano, Koji
    Sasaki, Hidetaka
    Kamiya, Takashi
    Shimosegawa, Eku
    Kato, Hiroki
    Cardinale, Jens
    Tateishi, Ukihide
    Nonomura, Norio
    Giesel, Frederik L.
    ANNALS OF NUCLEAR MEDICINE, 2021, 35 (04) : 523 - 528
  • [30] High detection rate in [18F]PSMA-1007 PET: interim results focusing on biochemical recurrence in prostate cancer patients
    Watabe, Tadashi
    Uemura, Motohide
    Soeda, Fumihiko
    Naka, Sadahiro
    Ujike, Takeshi
    Hatano, Koji
    Sasaki, Hidetaka
    Kamiya, Takashi
    Shimosegawa, Eku
    Kato, Hiroki
    Cardinale, Jens
    Nonomura, Norio
    Giesel, Frederik
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
12345